MENU

ORIC Oric Pharmaceuticals Forecast, Technical & Fundamental Analysis

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology
ORIC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
ORIC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ORIC is expected to report earnings to -49 cents per share on March 25

Oric Pharmaceuticals ORIC Stock Earnings Reports
Q4'24
Est.
$-0.49
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.05
Q4'23
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of -49 cents, missing the estimate of -47 cents. With 96.14K shares outstanding, the current market capitalization sits at 723.77M.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WOFNX67.96-0.29
-0.42%
Allspring Opportunity Inst
FCAEX12.56-0.09
-0.71%
Fidelity Climate Action
JVARX43.33-0.34
-0.78%
JPMorgan Value Advantage R5
MPISX8.65-0.08
-0.92%
BNY Mellon Income Stock M
ACGGX12.52-0.31
-2.42%
American Century Global Gold A

ORIC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with DAWN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-0.39%
DAWN - ORIC
41%
Loosely correlated
-1.39%
KYMR - ORIC
40%
Loosely correlated
-3.45%
SVRA - ORIC
40%
Loosely correlated
-5.90%
ACLX - ORIC
40%
Loosely correlated
-5.68%
PRTA - ORIC
39%
Loosely correlated
-3.98%
More